We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Scientists Identify New Risk Factor for Diabetes

By Biotechdaily staff writers
Posted on 20 Oct 2006
In a breakthrough in the study of risk factors associated with type 1 diabetes, scientists have identified a particular variant of a gene that is more common in people with type 1 diabetes.

The breakthrough was announced by the Institute for Systems Biology (ISB, Seattle, Washington, USA), whose researchers identified a gene, ITPR3, associated with type 1 diabetes. More...
The ITPR3 gene regulates calcium flow within cells. The researchers found that one particular variant of ITPR3 is more common in people with type 1 diabetes, which may point to ITPR3 as a cause of the disease. The finding was reported in the October 2006 issue of the American Journal of Human Genetics. Both environmental and genetic factors are thought to contribute to the disease.

"Scientists having been working to understand the genetics of type 1 diabetes for thirty years. We have long known that the human leukocyte antigen [HLA] class II genes play an important role in risk for type 1 diabetes, but other involved genes have remained elusive,” said Jared Roach, M.D., Ph.D.,a senior research scientist at the ISB. "This study begins to examine one of those involved genes.”

The team, co-directed by Dr. Marta Janer, Ph.D., a senior research scientist at the ISB, analyzed genetic data from patients who had participated in the Swedish Childhood Diabetes study and the Diabetes Incidence in Sweden study, both based in Sweden and represented by Dr. Åke Lernmark of the University of Washington (Seattle, USA). The ITPR3 gene has been studied for years in the nervous system but has never been thought to cause diabetes. A number of studies have found that ITPR3 is abundant in pancreatic islets, which are the parts of the pancreas that contain the beta cells, indicating this protein may be important to the function of beta cells and that a defect may make beta cells more susceptible to an autoimmune attack.

At least in Sweden, ITPR3 may account for a significant portion of the previously unknown genetic risk for type 1 diabetes, concluded the researchers. Preliminary estimates suggest that ITPR3 may be responsible for approximately 20% of the cases of type 1 diabetes in Sweden.

ISB seeks to unravel the mysteries of human biology and identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The driving force behind its approach is the integration of biology, computation, and technology. This approach allows scientists to analyze all of the elements in a system rather than one gene or protein at a time.



Related Links:
Institute for Systems Biology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.